159 related articles for article (PubMed ID: 28801538)
1. Comparison of Acute Thrombogenicity for Metallic and Polymeric Bioabsorbable Scaffolds: Magmaris Versus Absorb in a Porcine Arteriovenous Shunt Model.
Waksman R; Lipinski MJ; Acampado E; Cheng Q; Adams L; Torii S; Gai J; Torguson R; Hellinga DM; Westman PC; Joner M; Zumstein P; Kolodgie FD; Virmani R
Circ Cardiovasc Interv; 2017 Aug; 10(8):. PubMed ID: 28801538
[TBL] [Abstract][Full Text] [Related]
2. Comparison of acute thrombogenicity for magnesium versus stainless steel stents in a porcine arteriovenous shunt model.
Lipinski MJ; Acampado E; Cheng Q; Adams L; Torii S; Gai J; Torguson R; Hellinga DG; Joner M; Harder C; Zumstein P; Finn AV; Kolodgie FD; Virmani R; Waksman R
EuroIntervention; 2019 Jan; 14(13):1420-1427. PubMed ID: 29741484
[TBL] [Abstract][Full Text] [Related]
3. Acute Thrombogenicity of a Durable Polymer Everolimus-Eluting Stent Relative to Contemporary Drug-Eluting Stents With Biodegradable Polymer Coatings Assessed Ex Vivo in a Swine Shunt Model.
Otsuka F; Cheng Q; Yahagi K; Acampado E; Sheehy A; Yazdani SK; Sakakura K; Euller K; Perkins LEL; Kolodgie FD; Virmani R; Joner M
JACC Cardiovasc Interv; 2015 Aug; 8(9):1248-1260. PubMed ID: 26292590
[TBL] [Abstract][Full Text] [Related]
4. Thrombogenicity and early vascular healing response in metallic biodegradable polymer-based and fully bioabsorbable drug-eluting stents.
Koppara T; Cheng Q; Yahagi K; Mori H; Sanchez OD; Feygin J; Wittchow E; Kolodgie FD; Virmani R; Joner M
Circ Cardiovasc Interv; 2015 Jun; 8(6):e002427. PubMed ID: 26022535
[TBL] [Abstract][Full Text] [Related]
5. Second-generation magnesium scaffold Magmaris: device design and preclinical evaluation in a porcine coronary artery model.
Waksman R; Zumstein P; Pritsch M; Wittchow E; Haude M; Lapointe-Corriveau C; Leclerc G; Joner M
EuroIntervention; 2017 Jul; 13(4):440-449. PubMed ID: 28262623
[TBL] [Abstract][Full Text] [Related]
6. Mechanical properties of the drug-eluting bioresorbable magnesium scaffold compared with polymeric scaffolds and a permanent metallic drug-eluting stent.
Barkholt TØ; Webber B; Holm NR; Ormiston JA
Catheter Cardiovasc Interv; 2020 Dec; 96(7):E674-E682. PubMed ID: 31710149
[TBL] [Abstract][Full Text] [Related]
7. Magnesium versus poly-L-lactic acid bioresorbable scaffolds: in vivo optical coherence tomography comparison of mechanical performance.
Abellás-Sequeiros RA; Ocaranza-Sanchez R; Galvaõ-Braga C; Marques J; Gonzalez-Juanatey C
Arch Cardiol Mex; 2020; 90(1):8-15. PubMed ID: 31996867
[TBL] [Abstract][Full Text] [Related]
8. Long-term safety of an everolimus-eluting bioresorbable vascular scaffold and the cobalt-chromium XIENCE V stent in a porcine coronary artery model.
Otsuka F; Pacheco E; Perkins LE; Lane JP; Wang Q; Kamberi M; Frie M; Wang J; Sakakura K; Yahagi K; Ladich E; Rapoza RJ; Kolodgie FD; Virmani R
Circ Cardiovasc Interv; 2014 Jun; 7(3):330-42. PubMed ID: 24895447
[TBL] [Abstract][Full Text] [Related]
9. Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
Onuma Y; Serruys PW; Muramatsu T; Nakatani S; van Geuns RJ; de Bruyne B; Dudek D; Christiansen E; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Garcia-Garcia HM; Veldhof S; Rapoza R; Ormiston JA
JACC Cardiovasc Interv; 2014 Dec; 7(12):1400-11. PubMed ID: 25523532
[TBL] [Abstract][Full Text] [Related]
10. Magmaris resorbable magnesium scaffold for the treatment of coronary heart disease: overview of its safety and efficacy.
Bennett J; De Hemptinne Q; McCutcheon K
Expert Rev Med Devices; 2019 Sep; 16(9):757-769. PubMed ID: 31345074
[No Abstract] [Full Text] [Related]
11. Comparison of clinical outcomes between Magmaris and Orsiro drug eluting stent at 12 months: Pooled patient level analysis from BIOSOLVE II-III and BIOFLOW II trials.
Hideo-Kajita A; Garcia-Garcia HM; Kolm P; Azizi V; Ozaki Y; Dan K; Ince H; Kische S; Abizaid A; Töelg R; Lemos PA; Van Mieghem NM; Verheye S; von Birgelen C; Christiansen EH; Wijns W; Lefèvre T; Windecker S; Waksman R; Haude M;
Int J Cardiol; 2020 Feb; 300():60-65. PubMed ID: 31718825
[TBL] [Abstract][Full Text] [Related]
12. Acute Mechanical Performance of Magmaris vs. DESolve Bioresorbable Scaffolds in a Real-World Scenario.
Boeder NF; Dörr O; Koepp T; Blachutzik F; Achenbach S; Elsässer A; Hamm CW; Nef HM
Front Cardiovasc Med; 2021; 8():696287. PubMed ID: 34195239
[No Abstract] [Full Text] [Related]
13. Vasomotor Function Comparative Assessment at 1 and 2 Years Following Implantation of the Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold and the Xience V Everolimus-Eluting Metallic Stent in Porcine Coronary Arteries: Insights From In Vivo Angiography, Ex Vivo Assessment, and Gene Analysis at the Stented/Scaffolded Segments and the Proximal and Distal Edges.
Gogas BD; Benham JJ; Hsu S; Sheehy A; Lefer DJ; Goodchild TT; Polhemus DJ; Bouchi YH; Hung OY; Yoo SY; Joshi U; Giddens DP; Veneziani A; Quyyumi A; Rapoza R; King SB; Samady H
JACC Cardiovasc Interv; 2016 Apr; 9(7):728-41. PubMed ID: 27056313
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo evaluation of a novel bioresorbable magnesium scaffold with different surface modifications.
Menze R; Wittchow E
J Biomed Mater Res B Appl Biomater; 2021 Sep; 109(9):1292-1302. PubMed ID: 33386677
[TBL] [Abstract][Full Text] [Related]
15. Intracoronary optical coherence tomography and histology of overlapping everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: the potential implications for clinical practice.
Farooq V; Serruys PW; Heo JH; Gogas BD; Onuma Y; Perkins LE; Diletti R; Radu MD; Räber L; Bourantas CV; Zhang Y; van Remortel E; Pawar R; Rapoza RJ; Powers JC; van Beusekom HM; Garcìa-Garcìa HM; Virmani R
JACC Cardiovasc Interv; 2013 May; 6(5):523-32. PubMed ID: 23702016
[TBL] [Abstract][Full Text] [Related]
16. A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial.
Serruys PW; Chevalier B; Dudek D; Cequier A; Carrié D; Iniguez A; Dominici M; van der Schaaf RJ; Haude M; Wasungu L; Veldhof S; Peng L; Staehr P; Grundeken MJ; Ishibashi Y; Garcia-Garcia HM; Onuma Y
Lancet; 2015 Jan; 385(9962):43-54. PubMed ID: 25230593
[TBL] [Abstract][Full Text] [Related]
17. Two-Year Outcomes for Patients with Non-ST-Elevation Acute Coronary Syndrome Treated with Magmaris and Absorb Bioresorbable Scaffolds in Large-Vessel Lesions.
Włodarczak A; Rola P; Włodarczak S; Szudrowicz M; Giniewicz K; Łanocha M; Jaroszewska-Pozorska J; Barycki M; Furtan Ł; Kędzierska M; Włodarczak P; Doroszko A; Lesiak M
J Pers Med; 2024 May; 14(5):. PubMed ID: 38793122
[TBL] [Abstract][Full Text] [Related]
18. Comparison of in vivo acute stent recoil between the bioresorbable everolimus-eluting coronary scaffolds (revision 1.0 and 1.1) and the metallic everolimus-eluting stent.
Onuma Y; Serruys PW; Gomez J; de Bruyne B; Dudek D; Thuesen L; Smits P; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Garcia-Garcia H; Ormiston JA;
Catheter Cardiovasc Interv; 2011 Jul; 78(1):3-12. PubMed ID: 21413120
[TBL] [Abstract][Full Text] [Related]
19. ABSORB II randomized controlled trial: a clinical evaluation to compare the safety, efficacy, and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-eluting coronary stent system in the treatment of subjects with ischemic heart disease caused by de novo native coronary artery lesions: rationale and study design.
Diletti R; Serruys PW; Farooq V; Sudhir K; Dorange C; Miquel-Hebert K; Veldhof S; Rapoza R; Onuma Y; Garcia-Garcia HM; Chevalier B
Am Heart J; 2012 Nov; 164(5):654-63. PubMed ID: 23137495
[TBL] [Abstract][Full Text] [Related]
20. Absorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 1-year results of a propensity score matching comparison: the BVS-EXAMINATION Study (bioresorbable vascular scaffold-a clinical evaluation of everolimus eluting coronary stents in the treatment of patients with ST-segment elevation myocardial infarction).
Brugaletta S; Gori T; Low AF; Tousek P; Pinar E; Gomez-Lara J; Scalone G; Schulz E; Chan MY; Kocka V; Hurtado J; Gomez-Hospital JA; Münzel T; Lee CH; Cequier A; Valdés M; Widimsky P; Serruys PW; Sabaté M
JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt B):189-197. PubMed ID: 25616924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
